| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1055/S-0030-1247129 |
| P698 | PubMed publication ID | 20175030 |
| P2093 | author name string | Masamichi Kojiro | |
| Tania Roskams | |||
| P433 | issue | 1 | |
| P921 | main subject | pathology | Q7208 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 17-25 | |
| P577 | publication date | 2010-02-19 | |
| P1433 | published in | Seminars in Liver Disease | Q15724477 |
| P1476 | title | Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis | |
| P478 | volume | 30 |
| Q28392783 | 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma |
| Q28394414 | 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma |
| Q91599660 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q64272871 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q26772334 | Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma |
| Q60309958 | Assessment of small hepatocellular carcinoma: perfusion quantification and time-concentration curve evaluation using color-coded and quantitative digital subtraction angiography |
| Q34681076 | CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects |
| Q38046107 | Cellular and molecular mechanisms of hepatocellular carcinoma: an update |
| Q36224770 | Characterization of diethylnitrosamine-induced liver carcinogenesis in Syrian golden hamsters |
| Q38495409 | Cirrhotic liver: What's that nodule? The LI-RADS approach. |
| Q46839072 | Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis |
| Q46088451 | Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. |
| Q89623916 | Controversies in the management of hepatocellular carcinoma |
| Q26864205 | Current concepts in the immunohistochemical evaluation of liver tumors |
| Q53272486 | Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. |
| Q57972656 | Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma |
| Q89824104 | Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute |
| Q58097155 | Diagnostik und Früherkennung des hepatozellulären Karzinoms |
| Q37317479 | Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging |
| Q30234830 | Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease |
| Q26851272 | Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics |
| Q35960157 | Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence |
| Q37688462 | Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma |
| Q33837122 | Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. |
| Q85203393 | Evolving strategies in the diagnosis of hepatocellular carcinoma |
| Q37901565 | Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis |
| Q35101651 | Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations |
| Q39056693 | Force-dependent breaching of the basement membrane |
| Q47842185 | From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma. |
| Q52668585 | Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression. |
| Q38238010 | Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma |
| Q84958635 | Hepatocellular carcinoma--resection or transplant? |
| Q34089545 | Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI |
| Q42114895 | Hepatocellular tumors: immunohistochemical analyses for classification and prognostication |
| Q57782429 | Histology/pathology |
| Q64927295 | Histopathologic features of hepatocellular carcinoma. |
| Q38791960 | Latest developments in precancerous lesions of hepatocellular carcinoma |
| Q35903794 | Liver cancer: Approaching a personalized care |
| Q35619951 | MRI features of hepatocellular carcinoma related to biologic behavior |
| Q37895618 | Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? |
| Q61337229 | Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model |
| Q34954493 | Molecular pathology of hepatic neoplasms: classification and clinical significance |
| Q30448048 | New paradigm for management of hepatocellular carcinoma by imaging |
| Q26822764 | Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging |
| Q90703325 | Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification |
| Q27027683 | Radiological diagnosis of hepatocellular carcinoma |
| Q28075361 | Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI |
| Q36359054 | Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria |
| Q37946756 | TGF-β in progression of liver disease |
| Q38928373 | Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma |
| Q39136491 | Vitronectin silencing inhibits hepatocellular carcinoma in vitro and in vivo. |
| Q99548916 | mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer |
Search more.